This study (known as REINFORCE) aims to work out if robot assisted surgery, a relatively new development, should be routinely available in the NHS and also to assess any barriers to its implementation.
Why this project?
Over the next 20 years, surgery performed with the help of a robot (called “robot-assisted surgery”) is expected to increase rapidly around the world, especially for cancer conditions. Previous research shows that when robot-assisted surgery has been introduced in some clinical areas, like urology, it can help surgeons be more precise and can reduce a patient’s hospital stay. Using robot-assisted surgery may also speed up training for surgeons to enable them to become experts more quickly.
We have designed the research to be able to measure the impact of robot-assisted surgery as it is introduced in the NHS and scaled up in other hospitals currently performing robotic surgery but planning to expand services. It will study the effects of robot assisted surgery as it is rolled out at 16 different NHS sites in a planned way. It will measure the safety and benefit of the new treatment as it is being rolled out. We will measure what happens to patients who get robot-assisted surgery as part of the service and compare their outcomes (e.g., complications, recovery time) to conventional surgery.
We will also track how introducing robot-assisted surgery impacts on the staff and the surgeons, and how it affects wider care in hospitals across the country. We will also work out how much robot-assisted surgery really costs and whether the benefits are value for money.
We have designed the study to be able to measure the impact of robot-assisted surgery as it is introduced in the UK and scaled up in other hospitals currently performing robotic surgery but planning to expand services. It will study the effects of robot assisted surgery as it is rolled out at different sites in a planned way. It will measure the safety and benefit of the new treatment as it is being rolled out.
We will measure what happens to patients who get robot-assisted surgery as part of the service and compare their outcomes (e,g., complications, recovery time) to conventional surgery. We will track how introducing robot-assisted surgery impacts on the staff and the surgeons, and how it affects wider care in hospitals across the country. We will also work out how much robot-assisted surgery really costs and whether the benefits are value for money.
Funding acknowledgement
This project is funded by the National Institute for Health Research (NIHR) Health and Social Care Delivery Research (HSDR) Programme (Ref: NIHR131537).
The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.